These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35242718)

  • 1. Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer.
    Li M; Xu J; Jiang C; Zhang J; Sun T
    Front Oncol; 2022; 12():842705. PubMed ID: 35242718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
    Yan Y; Wang X; Liu C; Jia J
    BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy.
    Li N; Gao L; Ge Y; Zhao L; Bai C; Wang Y
    Front Oncol; 2023; 13():1195848. PubMed ID: 37346066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy.
    Bai YG; Gao GX; Zhang H; Zhang S; Liu YH; Duan XN; Xu L
    Chin Med J (Engl); 2020 Mar; 133(5):552-560. PubMed ID: 32044815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion.
    Song QK; Ren J; Zhou XN; Wang XL; Song GH; Di LJ; Yu J; Hobeika A; Morse MA; Yuan YH; Yang HB; Lyerly HK
    Oncotarget; 2015 Dec; 6(38):41350-9. PubMed ID: 26462021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of lymphocyte subsets with the efficacy and prognosis of PD‑1 inhibitor therapy in advanced gastric cancer: results from a monocentric retrospective study.
    Wang X; Liu X; Dai H; Jia J
    BMC Gastroenterol; 2024 Mar; 24(1):113. PubMed ID: 38491354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of regulatory T cells and T lymphocyte subsets in peripheral blood in neoadjuvant chemotherapy for breast cancer.
    Mao XD; Chen SZ; Shen SQ; Liu KS
    Am J Cancer Res; 2023; 13(7):3091-3099. PubMed ID: 37559980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitor.
    Li P; Qin P; Fu X; Zhang G; Yan X; Zhang M; Zhang X; Yang J; Wang H; Ma Z
    Ann Palliat Med; 2021 Mar; 10(3):3039-3049. PubMed ID: 33849094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of CD4
    Li YL; Qin XQ; Guo LY; Hou XX; Chao Y; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1129-1135. PubMed ID: 39192409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.
    Tavares MC; Sampaio CD; Lima GE; Andrade VP; Gonçalves DG; Macedo MP; Cordeiro de Lima VC
    BMC Cancer; 2021 Aug; 21(1):901. PubMed ID: 34362334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.
    Gao G; Wang Z; Qu X; Zhang Z
    BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral cytotoxic T lymphocyte predicts first-line progression free survival in HER2-positive advanced breast cancer.
    Liu XR; Yu JJ; Song GH; Di LJ; Jiang HF; Yan Y; Liang X; Zhang RY; Ran R; Wang J; Bai H; Jia SD; Li HP
    Breast; 2021 Feb; 55():7-15. PubMed ID: 33296767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.
    Rao N; Qiu J; Wu J; Zeng H; Su F; Qiu K; Wu J; Yao H
    Chemotherapy; 2017; 62(4):246-255. PubMed ID: 28472798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD3+/CD4+ cells combined with myosteatosis predict the prognosis in patients who underwent gastric cancer surgery.
    Du Z; Xiao Y; Deng G; Song H; Xue Y; Song H
    J Cachexia Sarcopenia Muscle; 2024 Aug; 15(4):1587-1600. PubMed ID: 38894548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alterations in peripheral lymphocyte subsets predict the efficacy and prognosis of immune checkpoint inhibitors in hepatocellular carcinoma.
    Xie Q; Hu C; Luo C
    J Cancer; 2023; 14(15):2946-2955. PubMed ID: 37781071
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme.
    Jan CI; Tsai WC; Harn HJ; Shyu WC; Liu MC; Lu HM; Chiu SC; Cho DY
    Front Immunol; 2018; 9():727. PubMed ID: 29910795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of programmed cell death protein 1 on peripheral blood T-cell subsets is associated with poor prognosis in metastatic gastric cancer.
    Shi B; Li Q; Ma X; Gao Q; Li L; Chu J
    Oncol Lett; 2018 Oct; 16(4):4448-4454. PubMed ID: 30214579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
    Wang K; Shen T; Siegal GP; Wei S
    Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Peripheral Blood Biomarkers With Response to Anti-PD-1 Immunotherapy for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer: A Multicenter Cohort Study.
    Cheng YK; Chen DW; Chen P; He X; Li PS; Lin ZS; Chen SX; Ye SB; Lan P
    Front Immunol; 2022; 13():809971. PubMed ID: 35185898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical implication of CD45RA
    Hang J; Huang J; Zhou S; Wu L; Zhu Y; Zhu L; Zhou H; Xu K; Jiang H; Yang X
    Cancer Med; 2019 Mar; 8(3):1326-1335. PubMed ID: 30767430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.